| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1166 | 2020 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1133 | 2020 |
| Low-dose methotrexate for the prevention of atherosclerotic events PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ... New England Journal of Medicine 380 (8), 752-762, 2019 | 1127 | 2019 |
| 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis L Fraenkel, JM Bathon, BR England, EW St. Clair, T Arayssi, K Carandang, ... Arthritis & Rheumatology 73 (7), 1108-1123, 2021 | 977 | 2021 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 677* | 2021 |
| Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ KM D’Silva, N Serling-Boyd, R Wallwork, T Hsu, X Fu, EM Gravallese, ... Annals of the rheumatic diseases 79 (9), 1156-1162, 2020 | 304 | 2020 |
| A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of Internal Medicine 172 (12), 819-821, 2020 | 274* | 2020 |
| Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study B Lu, LT Hiraki, JA Sparks, S Malspeis, CY Chen, JA Awosogba, ... Annals of the rheumatic diseases 73 (11), 1914-1922, 2014 | 266 | 2014 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 241 | 2023 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 210 | 2021 |
| Rheumatoid arthritis and mortality among women during 36 years of prospective follow‐up: results from the Nurses’ Health Study JA Sparks, SC Chang, KP Liao, B Lu, AR Fine, DH Solomon, ... Arthritis care & research 68 (6), 753-762, 2016 | 200 | 2016 |
| Long-term dietary quality and risk of developing rheumatoid arthritis in women Y Hu, JA Sparks, S Malspeis, KH Costenbader, FB Hu, EW Karlson, B Lu Annals of the rheumatic diseases 76 (8), 1357-1364, 2017 | 174 | 2017 |
| Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women Y Hu, KH Costenbader, X Gao, M Al-Daabil, JA Sparks, DH Solomon, ... The American journal of clinical nutrition 100 (3), 959-967, 2014 | 169 | 2014 |
| Adverse effects of low-dose methotrexate: a randomized trial DH Solomon, RJ Glynn, EW Karlson, F Lu, C Corrigan, J Colls, C Xu, ... Annals of internal medicine 172 (6), 369-380, 2020 | 165 | 2020 |
| Rheumatoid arthritis disease activity predicting incident clinically‐apparent RA‐associated interstitial lung disease: A prospective cohort study JA Sparks, X He, J Huang, EA Fletcher, A Zaccardelli, HM Friedlander, ... Arthritis & Rheumatology 71 (9), 1472-1482, 2019 | 163* | 2019 |
| Communicating genetic risk information for common disorders in the era of genomic medicine DM Lautenbach, KD Christensen, JA Sparks, RC Green Annual review of genomics and human genetics 14, 491-513, 2013 | 160 | 2013 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 146 | 2021 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 122 | 2022 |
| Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts M Barbhaiya, SK Tedeschi, B Lu, S Malspeis, D Kreps, JA Sparks, ... Annals of the rheumatic diseases 77 (2), 196-202, 2018 | 114 | 2018 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 108 | 2021 |
Zachary S. WallacePhysician-Scientist, Rheumatology Unit, Massachusetts General HospitalVerified email at mgh.harvard.edu
